| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.08 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |